Suzanne P. Linn-Rasker

1.4k total citations
14 papers, 979 citations indexed

About

Suzanne P. Linn-Rasker is a scholar working on Rheumatology, Nephrology and Genetics. According to data from OpenAlex, Suzanne P. Linn-Rasker has authored 14 papers receiving a total of 979 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 4 papers in Nephrology and 4 papers in Genetics. Recurrent topics in Suzanne P. Linn-Rasker's work include Rheumatoid Arthritis Research and Therapies (9 papers), Systemic Lupus Erythematosus Research (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Suzanne P. Linn-Rasker is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (9 papers), Systemic Lupus Erythematosus Research (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Suzanne P. Linn-Rasker collaborates with scholars based in Netherlands, Switzerland and Germany. Suzanne P. Linn-Rasker's co-authors include T. Huizinga, F. C. Breedveld, F. van Gaalen, Brigit A. de Jong, René E. M. Toes, W J van Venrooij, C. L. Verweij, Jan Tijssen, Arie Berghout and Annemieke Roos and has published in prestigious journals such as Annals of the Rheumatic Diseases, The Journal of Rheumatology and Clinical Rheumatology.

In The Last Decade

Suzanne P. Linn-Rasker

13 papers receiving 935 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzanne P. Linn-Rasker Netherlands 9 748 296 139 132 93 14 979
T. Li United States 6 769 1.0× 237 0.8× 380 2.7× 281 2.1× 125 1.3× 6 1.0k
A. Krabben Netherlands 18 684 0.9× 94 0.3× 110 0.8× 165 1.3× 73 0.8× 26 862
Daniel J. Wallace United States 6 725 1.0× 184 0.6× 461 3.3× 112 0.8× 114 1.2× 9 896
Lee Suan Teh United Kingdom 12 941 1.3× 242 0.8× 639 4.6× 85 0.6× 188 2.0× 17 1.2k
Hilde Swinkels Netherlands 8 1.2k 1.6× 237 0.8× 164 1.2× 320 2.4× 188 2.0× 9 1.3k
H. R. Van Den Brink Netherlands 11 991 1.3× 83 0.3× 171 1.2× 351 2.7× 142 1.5× 14 1.2k
Sofia Ajeganova Sweden 22 984 1.3× 200 0.7× 352 2.5× 221 1.7× 150 1.6× 49 1.3k
Yehuda Shoenfeld Israel 17 949 1.3× 205 0.7× 612 4.4× 280 2.1× 198 2.1× 32 1.3k
G Sturfelt Sweden 12 760 1.0× 141 0.5× 574 4.1× 71 0.5× 109 1.2× 21 1.1k
Paul Emery United Kingdom 13 535 0.7× 65 0.2× 123 0.9× 141 1.1× 149 1.6× 21 820

Countries citing papers authored by Suzanne P. Linn-Rasker

Since Specialization
Citations

This map shows the geographic impact of Suzanne P. Linn-Rasker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne P. Linn-Rasker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne P. Linn-Rasker more than expected).

Fields of papers citing papers by Suzanne P. Linn-Rasker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne P. Linn-Rasker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne P. Linn-Rasker. The network helps show where Suzanne P. Linn-Rasker may publish in the future.

Co-authorship network of co-authors of Suzanne P. Linn-Rasker

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne P. Linn-Rasker. A scholar is included among the top collaborators of Suzanne P. Linn-Rasker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne P. Linn-Rasker. Suzanne P. Linn-Rasker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Jacobs, Johannes W. G., Suzanne P. Linn-Rasker, Ben G. F. Heggelman, et al.. (2020). AB0926 PERFORMANCE OF THE ACR-EULAR GOUT CLASSIFICATION CRITERIA FOR THE DIAGNOSIS GOUT IN CLINICAL PRACTICE: A ONE-YEAR FOLLOW-UP STUDY. Annals of the Rheumatic Diseases. 79. 1763–1764.
3.
Jacobs, Johannes W G, Suzanne P. Linn-Rasker, Ben G. F. Heggelman, et al.. (2020). Cardiovascular risk in patients with new gout diagnosis: is monosodium urate volume at ankles and feet on dual-energy computed tomography associated with previous cardiovascular events?. PubMed. 38(4). 763–766. 4 indexed citations
4.
Jacobs, Johannes W. G., Suzanne P. Linn-Rasker, Ben G. F. Heggelman, et al.. (2020). Cardiovascular risk in patients with new gout: should we reclassify the risk?. PubMed. 38(3). 533–535. 3 indexed citations
5.
6.
Linn-Rasker, Suzanne P., Ben G. F. Heggelman, Jacob M. van Laar, et al.. (2018). Gouty arthritis: decision-making following dual-energy CT scan in clinical practice, a retrospective analysis. Clinical Rheumatology. 37(7). 1879–1884. 21 indexed citations
7.
Rossato, Marzia, Ruth Fritsch‐Stork, Suzanne P. Linn-Rasker, et al.. (2018). RNA sequencing to predict response to TNF-α inhibitors reveals possible mechanism for nonresponse in smokers. Expert Review of Clinical Immunology. 14(7). 623–633. 5 indexed citations
8.
Nair, Sandhya, J. W. J. Bijlsma, M. J. van der Veen, et al.. (2013). Do Radiographic Joint Damage and Disease Activity Influence Functional Disability Through Different Mechanisms? Direct and Indirect Effects of Disease Activity in Established Rheumatoid Arthritis. The Journal of Rheumatology. 40(9). 1505–1512. 9 indexed citations
9.
Bakker, Marije F., Johannes W. G. Jacobs, Paco M J Welsing, et al.. (2011). Early clinical response to treatment predicts 5-year outcome in RA patients: follow-up results from the CAMERA study. Annals of the Rheumatic Diseases. 70(6). 1099–1103. 41 indexed citations
10.
Bakker, Marije F., Johannes W. G. Jacobs, Paco M J Welsing, et al.. (2010). Are switches from oral to subcutaneous methotrexate or addition of ciclosporin to methotrexate useful steps in a tight control treatment strategy for rheumatoid arthritis? A post hoc analysis of the CAMERA study. Annals of the Rheumatic Diseases. 69(10). 1849–1852. 39 indexed citations
11.
Linn-Rasker, Suzanne P., Annette H M van der Helm–van Mil, F. C. Breedveld, & T. Huizinga. (2006). Arthritis of the large joints—in particular, the knee—at first presentation is predictive for a high level of radiological destruction of the small joints in rheumatoid arthritis. Annals of the Rheumatic Diseases. 66(5). 646–650. 35 indexed citations
12.
Linn-Rasker, Suzanne P., et al.. (2005). Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles. Annals of the Rheumatic Diseases. 65(3). 366–371. 232 indexed citations
13.
Roos, Annemieke, Suzanne P. Linn-Rasker, Ron T. van Domburg, Jan Tijssen, & Arie Berghout. (2005). The Starting Dose of Levothyroxine in Primary Hypothyroidism Treatment. Archives of Internal Medicine. 165(15). 1714–1714. 103 indexed citations
14.
Gaalen, F. van, Suzanne P. Linn-Rasker, W J van Venrooij, et al.. (2004). Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: A prospective cohort study. Arthritis & Rheumatism. 50(3). 709–715. 470 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T. Li Breakdown of academic impact, for papers by A. Krabben Breakdown of academic impact, for papers by Daniel J. Wallace Breakdown of academic impact, for papers by Lee Suan Teh Breakdown of academic impact, for papers by Hilde Swinkels Breakdown of academic impact, for papers by H. R. Van Den Brink Breakdown of academic impact, for papers by Sofia Ajeganova Breakdown of academic impact, for papers by Yehuda Shoenfeld Breakdown of academic impact, for papers by G Sturfelt Breakdown of academic impact, for papers by Paul Emery
Rankless by CCL
2026